These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 9655129

  • 1. Pseudometabolic expression and phenotypic variability of calpain deficiency in two siblings.
    Pénisson-Besnier I, Richard I, Dubas F, Beckmann JS, Fardeau M.
    Muscle Nerve; 1998 Aug; 21(8):1078-80. PubMed ID: 9655129
    [Abstract] [Full Text] [Related]

  • 2. Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice.
    Richard I, Roudaut C, Marchand S, Baghdiguian S, Herasse M, Stockholm D, Ono Y, Suel L, Bourg N, Sorimachi H, Lefranc G, Fardeau M, Sébille A, Beckmann JS.
    J Cell Biol; 2000 Dec 25; 151(7):1583-90. PubMed ID: 11134085
    [Abstract] [Full Text] [Related]

  • 3. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy.
    Chae J, Minami N, Jin Y, Nakagawa M, Murayama K, Igarashi F, Nonaka I.
    Neuromuscul Disord; 2001 Sep 25; 11(6-7):547-55. PubMed ID: 11525884
    [Abstract] [Full Text] [Related]

  • 4. Clinical, pathological, and genetic features of limb-girdle muscular dystrophy type 2A with new calpain 3 gene mutations in seven patients from three Japanese families.
    Kawai H, Akaike M, Kunishige M, Inui T, Adachi K, Kimura C, Kawajiri M, Nishida Y, Endo I, Kashiwagi S, Nishino H, Fujiwara T, Okuno S, Roudaut C, Richard I, Beckmann JS, Miyoshi K, Matsumoto T.
    Muscle Nerve; 1998 Nov 25; 21(11):1493-501. PubMed ID: 9771675
    [Abstract] [Full Text] [Related]

  • 5. The phenotype of calpainopathy: diagnosis based on a multidisciplinary approach.
    Pollitt C, Anderson LV, Pogue R, Davison K, Pyle A, Bushby KM.
    Neuromuscul Disord; 2001 Apr 25; 11(3):287-96. PubMed ID: 11297944
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chromosome 15-linked limb-girdle muscular dystrophy: clinical phenotypes in Reunion Island and French metropolitan communities.
    Fardeau M, Eymard B, Mignard C, Tomé FM, Richard I, Beckmann JS.
    Neuromuscul Disord; 1996 Dec 25; 6(6):447-53. PubMed ID: 9027854
    [Abstract] [Full Text] [Related]

  • 8. Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle.
    Baghdiguian S, Richard I, Martin M, Coopman P, Beckmann JS, Mangeat P, Lefranc G.
    J Mol Med (Berl); 2001 Jun 25; 79(5-6):254-61. PubMed ID: 11485017
    [Abstract] [Full Text] [Related]

  • 9. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A.
    Baghdiguian S, Martin M, Richard I, Pons F, Astier C, Bourg N, Hay RT, Chemaly R, Halaby G, Loiselet J, Anderson LV, Lopez de Munain A, Fardeau M, Mangeat P, Beckmann JS, Lefranc G.
    Nat Med; 1999 May 25; 5(5):503-11. PubMed ID: 10229226
    [No Abstract] [Full Text] [Related]

  • 10. Limb-girdle muscular dystrophy in Guipúzcoa (Basque Country, Spain).
    Urtasun M, Sáenz A, Roudaut C, Poza JJ, Urtizberea JA, Cobo AM, Richard I, García Bragado F, Leturcq F, Kaplan JC, Martí Massó JF, Beckmann JS, López de Munain A.
    Brain; 1998 Sep 25; 121 ( Pt 9)():1735-47. PubMed ID: 9762961
    [Abstract] [Full Text] [Related]

  • 11. Calpainopathy: how broad is the spectrum of clinical variability?
    Starling A, de Paula F, Silva H, Vainzof M, Zatz M.
    J Mol Neurosci; 2003 Sep 25; 21(3):233-6. PubMed ID: 14645990
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling.
    Laure L, Suel L, Roudaut C, Bourg N, Ouali A, Bartoli M, Richard I, Danièle N.
    FEBS J; 2009 Feb 25; 276(3):669-84. PubMed ID: 19143834
    [Abstract] [Full Text] [Related]

  • 16. Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression.
    Fanin M, Nascimbeni AC, Fulizio L, Trevisan CP, Meznaric-Petrusa M, Angelini C.
    Am J Pathol; 2003 Nov 25; 163(5):1929-36. PubMed ID: 14578192
    [Abstract] [Full Text] [Related]

  • 17. Myopathy phenotype of transgenic mice expressing active site-mutated inactive p94 skeletal muscle-specific calpain, the gene product responsible for limb girdle muscular dystrophy type 2A.
    Tagawa K, Taya C, Hayashi Y, Nakagawa M, Ono Y, Fukuda R, Karasuyama H, Toyama-Sorimachi N, Katsui Y, Hata S, Ishiura S, Nonaka I, Seyama Y, Arahata K, Yonekawa H, Sorimachi H, Suzuki K.
    Hum Mol Genet; 2000 May 22; 9(9):1393-402. PubMed ID: 10814721
    [Abstract] [Full Text] [Related]

  • 18. Mutations of calpain 3 gene in patients with sporadic limb-girdle muscular dystrophy in Japan.
    Minami N, Nishino I, Kobayashi O, Ikezoe K, Goto Y, Nonaka I.
    J Neurol Sci; 1999 Dec 01; 171(1):31-7. PubMed ID: 10567047
    [Abstract] [Full Text] [Related]

  • 19. Localization of calpain 3 in human skeletal muscle and its alteration in limb-girdle muscular dystrophy 2A muscle.
    Keira Y, Noguchi S, Minami N, Hayashi YK, Nishino I.
    J Biochem; 2003 May 01; 133(5):659-64. PubMed ID: 12801918
    [Abstract] [Full Text] [Related]

  • 20. [A case of LGMD2A identified with both western blot analysis and immunostaining of calpain 3 in biopsied muscle].
    Ibi T, Jing L, Nakao N, Minami N, Sahashi K.
    Rinsho Shinkeigaku; 2000 Oct 01; 40(10):1023-7. PubMed ID: 11296367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.